600867 通化东宝
已收盘 10-23 15:00:00
资讯
新帖
简况
股市必读：通化东宝新发布《通化东宝关于2025年员工持股计划预留部分完成股票非交易过户的公告》
证券之星 · 10-15
股市必读：通化东宝新发布《通化东宝关于2025年员工持股计划预留部分完成股票非交易过户的公告》
通化东宝（600867）披露2025年员工持股计划预留部分完成股票非交易过户，10月13日股价下跌0.13%
证券之星 · 10-13
通化东宝（600867）披露2025年员工持股计划预留部分完成股票非交易过户，10月13日股价下跌0.13%
股市必读：通化东宝新发布《通化东宝关于2025年员工持股计划首次授予第一个锁定期解锁条件成就暨锁定期届满的公告》
证券之星 · 10-08
股市必读：通化东宝新发布《通化东宝关于2025年员工持股计划首次授予第一个锁定期解锁条件成就暨锁定期届满的公告》
股市必读：通化东宝新发布《通化东宝关于控股股东股份解押及再质押公告》
证券之星 · 09-30
股市必读：通化东宝新发布《通化东宝关于控股股东股份解押及再质押公告》
通化东宝（600867）披露2025年员工持股计划首次授予第一个锁定期解锁条件成就暨锁定期届满公告，9月29日股价下跌0.65%
证券之星 · 09-29
通化东宝（600867）披露2025年员工持股计划首次授予第一个锁定期解锁条件成就暨锁定期届满公告，9月29日股价下跌0.65%
股市必读：通化东宝新发布《通化东宝关于控股股东股份解押及再质押公告》
证券之星 · 09-29
股市必读：通化东宝新发布《通化东宝关于控股股东股份解押及再质押公告》
研报掘金丨东方证券：维持通化东宝“买入”评级，新品与出海接力增长
格隆汇 · 09-03
研报掘金丨东方证券：维持通化东宝“买入”评级，新品与出海接力增长
股市必读：通化东宝新发布《通化东宝第十二届董事会第四次会议决议公告》
证券之星 · 09-01
股市必读：通化东宝新发布《通化东宝第十二届董事会第四次会议决议公告》
通化东宝（600867）披露2025年员工持股计划预留部分分配公告，8月31日股价下跌0.86%
证券之星 · 08-31
通化东宝（600867）披露2025年员工持股计划预留部分分配公告，8月31日股价下跌0.86%
每周股票复盘：通化东宝（600867）Q2净利增59.07%，股东户数增11.19%
证券之星 · 08-30
每周股票复盘：通化东宝（600867）Q2净利增59.07%，股东户数增11.19%
研报掘金丨平安证券：维持通化东宝“推荐”评级，国际化战略多点突破
格隆汇 · 08-26
研报掘金丨平安证券：维持通化东宝“推荐”评级，国际化战略多点突破
股市必读：通化东宝中报 - 第二季度单季净利润同比增长59.07%
证券之星 · 08-26
股市必读：通化东宝中报 - 第二季度单季净利润同比增长59.07%
图解通化东宝中报：第二季度单季净利润同比增长59.07%
证券之星 · 08-25
图解通化东宝中报：第二季度单季净利润同比增长59.07%
通化东宝（600867）披露2026年半年度报告，8月24日股价下跌1.97%
证券之星 · 08-24
通化东宝（600867）披露2026年半年度报告，8月24日股价下跌1.97%
通化东宝：公司将于9月3日召开2026年半年度业绩说明会
证券日报网 · 08-24
通化东宝：公司将于9月3日召开2026年半年度业绩说明会
通化东宝最新公告：决定终止THDBH110/THDBH110胶囊研发项目并计提资产减值准备
证券之星 · 08-24
通化东宝最新公告：决定终止THDBH110/THDBH110胶囊研发项目并计提资产减值准备
每周股票复盘：通化东宝（600867）东宝集团累计质押5.82亿股
证券之星 · 08-16
每周股票复盘：通化东宝（600867）东宝集团累计质押5.82亿股
股市必读：通化东宝新发布《通化东宝关于控股股东股份解押及再质押公告》
证券之星 · 08-13
股市必读：通化东宝新发布《通化东宝关于控股股东股份解押及再质押公告》
通化东宝：胰岛素西林瓶生产线项目目前处于建设推进阶段
证券之星 · 08-12
通化东宝：胰岛素西林瓶生产线项目目前处于建设推进阶段
通化东宝（600867）披露参与认购特宝生物可转债结果，8月11日股价上涨0.84%
证券之星 · 08-11
通化东宝（600867）披露参与认购特宝生物可转债结果，8月11日股价上涨0.84%
公司概况
公司名称：
通化东宝药业股份有限公司
所属行业：
医药制造业
上市日期：
1994-08-24
主营业务：
通化东宝药业股份有限公司的主营业务是糖尿病及内分泌治疗领域生物制品、中成药、化学药等药品的研发、生产和销售。公司的主要产品是人胰岛素原料药、人胰岛素注射剂（注册商标：甘舒霖）、甘精胰岛素原料药、甘精胰岛素注射液（注册商标：平舒霖）、门冬胰岛素原料药、门冬胰岛素注射液、预混型门冬胰岛素（门冬胰岛素30注射液与门冬胰岛素50注射液）（注册商标：锐舒霖）、利拉鲁肽注射液（注册商标：统博力）、恩格列净片（注册商标：唐捷恩）、镇脑宁胶囊、糖尿病相关的医疗器械等。
发行价格：
6.50
{"stockData":{"symbol":"600867","market":"SH","secType":"STK","nameCN":"通化东宝","latestPrice":7.78,"timestamp":1792738800000,"preClose":7.62,"halted":0,"volume":16935428,"delay":0,"changeRate":0.021,"floatShares":1959000000,"shares":1959000000,"eps":0.6623,"marketStatus":"已收盘","change":0.16,"latestTime":"10-23 15:00:00","open":7.6,"high":7.8,"low":7.54,"amount":130000000,"amplitude":0.0341,"askPrice":7.78,"askSize":191,"bidPrice":7.77,"bidSize":420,"shortable":0,"etf":0,"ttmEps":0.6623,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1792978200000},"marketStatusCode":5,"adr":0,"adjPreClose":7.62,"symbolType":"stock","openAndCloseTimeList":[[1792719000000,1792726200000],[1792731600000,1792738800000]],"highLimit":8.38,"lowLimit":6.86,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1958542829,"isCdr":false,"pbRate":2.23,"roa":"--","peRate":11.746942,"roe":"4.07%","epsLYR":0.62,"committee":-0.220877,"marketValue":15237000000,"turnoverRate":0.0086,"status":0,"floatMarketCap":15237000000},"requestUrl":"/m/hq/s/600867/wiki","defaultTab":"wiki","newsList":[{"id":"2675370321","title":"股市必读：通化东宝新发布《通化东宝关于2025年员工持股计划预留部分完成股票非交易过户的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675370321","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675370321?lang=zh_cn&edition=full","pubTime":"2026-10-15 02:16","pubTimestamp":1792001771,"startTime":"0","endTime":"0","summary":"截至2026年10月14日收盘，通化东宝报收于7.85元，上涨0.0%，换手率0.59%，成交量11.52万手，成交额9055.73万元。当日关注点交易信息汇总：10月14日主力资金净流入386.99万元，占总成交额4.27%。公司公告汇总：通化东宝于2026年10月9日完成2025年员工持股计划预留部分股票非交易过户，数量1,787,817股，占总股本0.091%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500001808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0188","600867","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675368674","title":"通化东宝（600867）披露2025年员工持股计划预留部分完成股票非交易过户，10月13日股价下跌0.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675368674","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675368674?lang=zh_cn&edition=full","pubTime":"2026-10-13 22:24","pubTimestamp":1791901463,"startTime":"0","endTime":"0","summary":"截至2026年10月13日收盘，通化东宝报收于7.85元，较前一交易日下跌0.13%，最新总市值为153.75亿元。近日，通化东宝药业股份有限公司发布《关于2025年员工持股计划预留部分完成股票非交易过户的公告》。公告显示，公司于2026年10月9日完成2025年员工持股计划预留部分的股票非交易过户，过户股票数量为1,787,817股，占公司总股本的0.091%，过户价格为3.99元/股。本次预留部分授予完成后，员工持股计划份额已全部分配完毕。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300039967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","600867","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673126930","title":"股市必读：通化东宝新发布《通化东宝关于2025年员工持股计划首次授予第一个锁定期解锁条件成就暨锁定期届满的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673126930","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673126930?lang=zh_cn&edition=full","pubTime":"2026-10-08 02:00","pubTimestamp":1791396043,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘，通化东宝报收于7.86元，上涨2.34%，换手率1.03%，成交量20.21万手，成交额1.58亿元。公司公告汇总：通化东宝2025年员工持股计划首次授予第一个锁定期于9月30日届满，解锁条件成就，可解锁股票263.85万股，占总股本0.13%。公司2025年度营业收入同比增长46.66%，扣除非经常性损益后的净利润剔除股份支付影响后为38,053.23万元，公司层面业绩考核达标。69名持有人个人考核结果为良好，解锁系数为100%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800001081.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0188","600867","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671953241","title":"股市必读：通化东宝新发布《通化东宝关于控股股东股份解押及再质押公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2671953241","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671953241?lang=zh_cn&edition=full","pubTime":"2026-09-30 02:05","pubTimestamp":1790705113,"startTime":"0","endTime":"0","summary":"公司公告汇总：控股股东东宝集团完成1400万股股份解押及再质押，累计质押股份数占公司总股本29.71%。公司公告汇总通化东宝关于控股股东股份解押及再质押公告控股股东东宝集团于2026年9月23日解除质押给中国建设银行股份有限公司通化分行的14,000,000股股份，并于2026年9月24日再次将相同数量股份质押给该行，用于偿还债务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000002369.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","600867","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671248569","title":"通化东宝（600867）披露2025年员工持股计划首次授予第一个锁定期解锁条件成就暨锁定期届满公告，9月29日股价下跌0.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671248569","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671248569?lang=zh_cn&edition=full","pubTime":"2026-09-29 22:21","pubTimestamp":1790691676,"startTime":"0","endTime":"0","summary":"截至2026年9月29日收盘，通化东宝报收于7.68元，较前一交易日下跌0.65%，最新总市值为150.42亿元。该股当日开盘7.73元，最高7.78元，最低7.66元，成交额达8272.28万元，换手率为0.55%。近日，通化东宝药业股份有限公司召开董事会，审议通过2025年员工持股计划首次授予第一个锁定期解锁条件成就的议案。本次可解锁股票数量为263.85万股，占公司总股本的0.13%。69名持有人个人考核结果为良好，解锁系数为100%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900040379.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0196","BK0239","600867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671254891","title":"股市必读：通化东宝新发布《通化东宝关于控股股东股份解押及再质押公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2671254891","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671254891?lang=zh_cn&edition=full","pubTime":"2026-09-29 01:15","pubTimestamp":1790615715,"startTime":"0","endTime":"0","summary":"公司公告汇总：控股股东东宝集团于9月23日解押1400万股、9月24日等量再质押，累计质押股份数占公司总股本29.71%。公司公告汇总通化东宝关于控股股东股份解押及再质押公告通化东宝药业股份有限公司控股股东东宝集团于2026年9月23日解除质押给中国建设银行股份有限公司通化分行的14,000,000股股份，并于2026年9月24日再次将相同数量股份质押给该行，用于偿还债务。东宝集团及其一致行动人合计质押股份占其持股总数的90.73%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900001577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","600867","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664831824","title":"研报掘金丨东方证券：维持通化东宝“买入”评级，新品与出海接力增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2664831824","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664831824?lang=zh_cn&edition=full","pubTime":"2026-09-03 14:47","pubTimestamp":1788418044,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["600867","BK0012","BK0188","BK0239","BK0183","600958","BK0276","BK0196","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664071570","title":"股市必读：通化东宝新发布《通化东宝第十二届董事会第四次会议决议公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664071570","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664071570?lang=zh_cn&edition=full","pubTime":"2026-09-01 01:28","pubTimestamp":1788197291,"startTime":"0","endTime":"0","summary":"公司公告汇总：通化东宝第十二届董事会第四次会议审议通过两项员工持股计划预留部分受让价格调整及份额分配事项，涉及总股票数量241.782万股，对应受让价格分别调整为3.99元/股和4.09元/股。公司公告汇总通化东宝第十二届董事会第四次会议决议公告通化东宝第十二届董事会第四次会议审议通过多项议案。相关议案已获董事会薪酬与考核委员会审议通过，部分议案涉及关联董事回避表决。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100001958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600867","BK0188","BK0239","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663009706","title":"通化东宝（600867）披露2025年员工持股计划预留部分分配公告，8月31日股价下跌0.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663009706","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663009706?lang=zh_cn&edition=full","pubTime":"2026-08-31 22:17","pubTimestamp":1788185863,"startTime":"0","endTime":"0","summary":"截至2026年8月31日收盘，通化东宝报收于8.11元，较前一交易日下跌0.86%，最新总市值为158.84亿元。该股当日开盘8.16元，最高8.17元，最低8.07元，成交额达1.2亿元，换手率为0.76%。近日，通化东宝发布关于2025年员工持股计划预留部分分配的公告。本次预留份额授予对象为公司董事、高级管理人员及核心技术（业务）骨干，共计不超过18人，其中董事王晓东、董事会秘书吴灵犀各认购90.00万股，合计占预留份额的50.34%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100037072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600867","BK0188","BK0196","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663416010","title":"每周股票复盘：通化东宝（600867）Q2净利增59.07%，股东户数增11.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663416010","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663416010?lang=zh_cn&edition=full","pubTime":"2026-08-30 03:37","pubTimestamp":1788032229,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，通化东宝报收于8.18元，较上周的8.11元上涨0.86%。股本股东变化股东户数变动截至2026年6月30日，公司股东户数为11.47万户，较3月31日增加1.15万户，增幅11.19%。公司公告汇总通化东宝2026年半年度报告摘要本报告期末总资产为7,829,509,474.28元，比上年度末减少1.54%；归属于上市公司股东的净资产为6,834,686,041.16元，比上年同期减少3.80%。通化东宝关于研发项目终止暨计提资产减值准备的公告公司于2026年8月24日召开董事会，审议通过终止THDBH110/THDBH110胶囊研发项目的议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0196","600867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662350793","title":"研报掘金丨平安证券：维持通化东宝“推荐”评级，国际化战略多点突破","url":"https://stock-news.laohu8.com/highlight/detail?id=2662350793","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662350793?lang=zh_cn&edition=full","pubTime":"2026-08-26 15:19","pubTimestamp":1787728763,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0188","BK0196","600867","BK0239","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662526647","title":"股市必读：通化东宝中报 - 第二季度单季净利润同比增长59.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662526647","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662526647?lang=zh_cn&edition=full","pubTime":"2026-08-26 04:36","pubTimestamp":1787690174,"startTime":"0","endTime":"0","summary":"截至2026年8月25日收盘，通化东宝报收于8.1元，上涨1.89%，换手率1.34%，成交量26.24万手，成交额2.14亿元。业绩披露要点：2026年第二季度归母净利润1.69亿元，同比增长59.07%。公司公告汇总：董事会审议通过终止THDBH110/THDBH110胶囊研发项目，并对资本化金额1,688.54万元全额计提资产减值准备。股本股东变化股东户数变动截至2026年6月30日公司股东户数为11.47万户，较3月31日增加1.15万户，增幅为11.19%；户均持股数量由1.9万股减少至1.71万股，户均持股市值为13.73万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600008052.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662208113","title":"图解通化东宝中报：第二季度单季净利润同比增长59.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662208113","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662208113?lang=zh_cn&edition=full","pubTime":"2026-08-25 01:15","pubTimestamp":1787591727,"startTime":"0","endTime":"0","summary":"证券之星消息，通化东宝2026年中报显示，上半年度公司主营收入15.53亿元，同比上升11.13%；归母净利润2.96亿元，同比上升37.32%；扣非净利润2.96亿元，同比上升35.55%；其中2026年第二季度，公司单季度主营收入8.05亿元，同比上升7.96%；单季度归母净利润1.69亿元，同比上升59.07%；单季度扣非净利润1.69亿元，同比上升55.67%；负债率12.95%，投资收益3672.16万元，财务费用486.95万元，毛利率70.79%。财报数据概要请见下图:本文数据来源于通化东宝2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500003433.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600867"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661272892","title":"通化东宝（600867）披露2026年半年度报告，8月24日股价下跌1.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661272892","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661272892?lang=zh_cn&edition=full","pubTime":"2026-08-24 22:21","pubTimestamp":1787581300,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘，通化东宝报收于7.95元，较前一交易日下跌1.97%，最新总市值为155.7亿元。该股当日开盘8.1元，最高8.13元，最低7.9元，成交额达2.24亿元，换手率为1.43%。近日，通化东宝药业股份有限公司披露2026年半年度报告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400037261.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600867","BK0196","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661790272","title":"通化东宝：公司将于9月3日召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2661790272","media":"证券日报网","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661790272?lang=zh_cn&edition=full","pubTime":"2026-08-24 21:31","pubTimestamp":1787578260,"startTime":"0","endTime":"0","summary":"证券日报网讯8月24日，通化东宝发布公告称，公司2026年半年度业绩说明会定于2026年9月3日14：00-15：00召开。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-24/doc-inipmsvn5998108.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-24/doc-inipmsvn5998108.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["600867","BK0188","BK0196","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661220980","title":"通化东宝最新公告：决定终止THDBH110/THDBH110胶囊研发项目并计提资产减值准备","url":"https://stock-news.laohu8.com/highlight/detail?id=2661220980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661220980?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:12","pubTimestamp":1787566344,"startTime":"0","endTime":"0","summary":"通化东宝(600867.SH)公告称，公司决定终止THDBH110/THDBH110胶囊研发项目，并对该项目研发资本化金额全额计提资产减值准备，合计1688.54万元，将减少2026年半年度利润总额1688.54万元。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400025929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","600867","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659175404","title":"每周股票复盘：通化东宝（600867）东宝集团累计质押5.82亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2659175404","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659175404?lang=zh_cn&edition=full","pubTime":"2026-08-16 01:57","pubTimestamp":1786816630,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，通化东宝报收于8.57元，较上周的8.42元上涨1.78%。本周，通化东宝8月11日盘中最高价报8.82元。本次解押及再质押后，东宝集团累计质押股份581,939,472股，占其所持公司股份的93.94%，占公司总股本的29.71%。通化东宝药业股份有限公司控股股东东宝集团于2026年8月11日解除质押32,000,000股，并同日将相同数量股份重新质押给交通银行股份有限公司通化分行，用于补充流动资金。东宝集团及其一致行动人合计质押股份占其所持股份总额的90.73%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600000367.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK0188","600867","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659390117","title":"股市必读：通化东宝新发布《通化东宝关于控股股东股份解押及再质押公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2659390117","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659390117?lang=zh_cn&edition=full","pubTime":"2026-08-13 01:05","pubTimestamp":1786554315,"startTime":"0","endTime":"0","summary":"截至2026年8月12日收盘，通化东宝报收于8.39元，下跌0.71%，换手率1.48%，成交量28.92万手，成交额2.45亿元。公司公告汇总：控股股东东宝集团于8月10日、8月11日分别完成两笔各1900万股、3200万股的股份解押及再质押，累计质押股份数维持581,939,472股，占其所持股份93.94%、占公司总股本29.71%。公司公告汇总：通化东宝以16,204.20万元认购特宝生物可转债1,620,420张，该债券将于8月13日在上交所上市，公司承诺六个月内不减持。公告明确本次质押不影响公司生产经营和控制权稳定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300000892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600867","BK0196","BK0239","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658922954","title":"通化东宝：胰岛素西林瓶生产线项目目前处于建设推进阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2658922954","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658922954?lang=zh_cn&edition=full","pubTime":"2026-08-12 15:33","pubTimestamp":1786520001,"startTime":"0","endTime":"0","summary":"证券之星消息，通化东宝(600867)08月12日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘你好！看到“通化县发布”8月8日新闻，提及贵司“西林瓶项目”建设，我想了解项目建设缘由、建设规模、建设进度等方面的情况，希望回复，谢谢！通化东宝回复：感谢您对公司的关注。公司胰岛素西林瓶生产线项目目前处于建设推进阶段，设计产能为 4,000 万支。该项目主要用于扩大公司制剂灌装能力，匹配快速增长的海外出口订单增量需求，是公司国际化产能布局的重要组成部分。本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200021013.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","600867","BK0188","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658916091","title":"通化东宝（600867）披露参与认购特宝生物可转债结果，8月11日股价上涨0.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658916091","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658916091?lang=zh_cn&edition=full","pubTime":"2026-08-11 22:20","pubTimestamp":1786458029,"startTime":"0","endTime":"0","summary":"截至2026年8月11日收盘，通化东宝报收于8.45元，较前一交易日上涨0.84%，最新总市值为165.5亿元。该股当日开盘8.37元，最高8.82元，最低8.36元，成交额达4.22亿元，换手率为2.52%。近日，通化东宝发布《关于行使优先配售权参与认购厦门特宝生物工程股份有限公司向不特定对象发行可转换公司债券的结果公告》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100038349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","600867","BK0188","BK0196","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1792744056836,"stockEarnings":[{"period":"1week","weight":-0.013},{"period":"1month","weight":-0.0318},{"period":"3month","weight":-0.0218},{"period":"6month","weight":-0.1774},{"period":"1year","weight":-0.1006},{"period":"ytd","weight":-0.0324}],"compareEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0744},{"period":"3month","weight":-0.0409},{"period":"6month","weight":-0.1034},{"period":"1year","weight":-0.0653},{"period":"ytd","weight":-0.0783}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"通化东宝药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"114726人(较上一季度增加11.19%)","perCapita":"17071股","listingDate":"1994-08-24","address":"吉林省通化市通化县东宝新村","registeredCapital":"195854万元","survey":" 通化东宝药业股份有限公司的主营业务是糖尿病及内分泌治疗领域生物制品、中成药、化学药等药品的研发、生产和销售。公司的主要产品是人胰岛素原料药、人胰岛素注射剂（注册商标：甘舒霖）、甘精胰岛素原料药、甘精胰岛素注射液（注册商标：平舒霖）、门冬胰岛素原料药、门冬胰岛素注射液、预混型门冬胰岛素（门冬胰岛素30注射液与门冬胰岛素50注射液）（注册商标：锐舒霖）、利拉鲁肽注射液（注册商标：统博力）、恩格列净片（注册商标：唐捷恩）、镇脑宁胶囊、糖尿病相关的医疗器械等。","listedPrice":6.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"通化东宝(600867)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供通化东宝(600867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"通化东宝,600867,通化东宝股票,通化东宝股票老虎,通化东宝股票老虎国际,通化东宝行情,通化东宝股票行情,通化东宝股价,通化东宝股市,通化东宝股票价格,通化东宝股票交易,通化东宝股票购买,通化东宝股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"通化东宝(600867)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供通化东宝(600867)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}